You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

[18-F]-DCFPyL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Carcinoma Trial in

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 19, 2023

Carcinoma of Prostate Trial in Toronto (18F-DCFPyL)

Active, not recruiting
  • Carcinoma of Prostate
  • 18F-DCFPyL
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 31, 2022

Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

Not yet recruiting
  • Prostate Cancer
  • Biochemically Recurrent
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,

Enrolling by invitation
  • Prostate Neoplasms
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Localized Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL)

Recruiting
  • Localized Prostate Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))

Not yet recruiting
  • Prostate Cancer
  • Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
  • (no location specified)
Jan 26, 2023

Metastatic Prostate Cancer Trial in New York ([F-18] DCFPyL, PET/CT imaging)

Active, not recruiting
  • Metastatic Prostate Cancer
  • [F-18] DCFPyL
  • PET/CT imaging
  • New York, New York
    Columbia University Irving Medical Center
May 6, 2022

Schwannomas, Malignant Tumors Trial in Baltimore (18F-DCFPyL Injection)

Completed
  • Schwannomas
  • Malignant Tumors
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Jan 9, 2023

Prostate Cancer Trial in Montreal (18F-DCFPyL PET/CT)

Enrolling by invitation
  • Prostate Cancer
  • 18F-DCFPyL PET/CT
  • Montreal, Quebec, Canada
    Jewish General Hospital
May 3, 2022

Prostate Carcinoma Trial in Duarte (procedure, other, device)

Recruiting
  • Prostate Carcinoma
  • Computed Tomography
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Prostatic Tumors Trial in New York (18F- DCFPyL PET/CT)

Active, not recruiting
  • Prostatic Neoplasms
  • 18F- DCFPyL PET/CT
  • New York, New York
    Columbia University Irving Medical Center
May 6, 2022

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Active, not recruiting
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    SKCCC
Apr 5, 2022

Prostate Cancer Trial in Pittsburgh (18F-DCFPyL)

Active, not recruiting
  • Prostate Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 8, 2022

Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])

Not yet recruiting
  • Prostate Cancer
  • Piflufolastat F 18 Intravenous Solution [PYLARIFY]
  • (no location specified)
Oct 3, 2023

Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)

Recruiting
  • Breast Cancer
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin School of Medicine and Public Health
Oct 18, 2022

Prostate Carcinoma Trial in Chicago (Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol)

Not yet recruiting
  • Prostate Carcinoma
  • Fluorine F 18 DCFPyL
  • +6 more
  • Chicago, Illinois
    Northwestern University
Aug 2, 2022

Prostate Cancer Trial in Stanford (F18-DCFPyL, Gadolinium, Positron emission tomography (PET)/Magnetic Resonance Imaging (MRI)

Temporarily not available
  • Prostate Cancer
  • Stanford, California
    Stanford University
Apr 4, 2022

Prostate Cancer Diagnosis Trial in Los Angeles (diagnostic test, other, drug)

Not yet recruiting
  • Prostate Cancer Diagnosis
  • PSMA PET scan
  • +2 more
  • Los Angeles, California
    VA Greater Los Angeles Healthcare System
Apr 20, 2023

Prostate Adenocarcinoma, PSA Level Greater Than 0.2, PSA Level Greater Than or Equal to Two Trial in Palo Alto (procedure,

No longer available
  • Prostate Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jan 6, 2022

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Completed
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Dec 14, 2021

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Withdrawn
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Dec 14, 2021

Prostatic Tumors, Prostate Cancer, Prostate Adenocarcinoma Trial run by the National Cancer Institute (NCI) (18F-DCFPyL,

Not yet recruiting
  • Prostatic Neoplasms
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Post Prostatectomy Trial in Toronto ([18F]DCFPyL PET/MRI scan, Stereotactic Ablative Radiotherapy)

Recruiting
  • Post Prostatectomy
  • [18F]DCFPyL PET/MRI scan
  • Stereotactic Ablative Radiotherapy
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Dec 31, 2021

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Recruiting
  • Prostatic Neoplasms
  • Prostate Cancer
  • PSMA PET/CT scan
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 15, 2021

Prostate Cancer, Prostate Cancer Metastatic, Prostatic Tumor Trial in Vancouver (18F-DCFPyL PET/CT scan, Placebo drink, MSG

Completed
Has Results
  • Prostate Cancer
  • +2 more
  • 18F-DCFPyL PET/CT scan
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 15, 2021